Introduction {#s01}
============

Murine caspase-11 (caspase-4 and caspase-5 in humans) mediates noncanonical inflammasome signaling, leading to pyroptotic cell death in response to Gram-negative bacteria infection ([@bib18]; [@bib8]; [@bib27]; [@bib1]). Cytoplasmic LPS derived from invading Gram-negative bacteria is the pathogen-associated molecular pattern that activates caspase-11 ([@bib15]; [@bib19]). Mechanistically, LPS binds directly to the caspase recruitment domain (CARD) of caspase-11 and initiates oligomerization and proximity-induced activation of caspase-11 catalytic activity ([@bib31]). Activated caspase-11 proteolytically cleaves gasdermin-D (GSDMD) to create a 30-kD, pore-forming GSDMD N-terminus fragment (GSDMD-NT) that can insert itself into the cell membrane to form pores. GSDMD-NT pore formation immediately causes an ionic gradient loss, leading to osmotic burst and cell membrane rupture (pyroptosis; [@bib20]; [@bib32]; [@bib3]; [@bib12]; [@bib21]; [@bib30]). Like many bacterial pore-forming toxins (e.g., listeriolysin-O), pore-forming GSDMD-NT also triggers NLRP3 sensor-mediated caspase-1 activation, leading to proteolytic activation of proinflammatory cytokines (IL-1β and IL-18; [@bib23]; [@bib18], [@bib20]). A robust level of activated mature IL-1β and other inflammatory intracellular danger-associated molecular patterns are passively released through the GSDMD pore and/or plasma cell membrane gaps created by a secondary osmotic burst.

Inflammatory caspases (caspase-1/4/5/11) that contain CARD domains can trigger pyroptosis through limited proteolysis of GSDMD. In addition, caspase-1 can cleave itself at multiple aspartic acid residues located at internal linkers that bridge the CARD domain, large subunit (p20), and small subunit (p10) ([@bib35]; [@bib37]; [@bib7]; [@bib14]). Previous studies, including Thornberry et al.'s initial discovery of caspase-1, demonstrate that a caspase-1 heterotetramer (p20/p10)~2~ complex represents an enzymatically active form which efficiently cleaves pro--IL-1β ([@bib35]; [@bib37]). Subsequently, two different groups examined the role of caspase-1 auto-processing in pyroptosis induction and IL-1β release by using *Casp1^−/−^* macrophages reconstituted with an auto-cleavage dead mutant form of caspase-1 ([@bib7]; [@bib14]). The mutant largely lost the ability to release IL-1β, but retained capacity to induce pyroptosis in response to inflammasome stimuli. Similarly, when overexpressed, caspase-11 can cleave itself at two internal sites: (1) VFVD~59~**↓**A or FSVD~80~**↓**P that removes the N-terminus CARD domain from the catalytic large subunit (CARD**↓**large subunit) and (2) MEAD~285~**↓**A, which segregates large and small catalytic subunits (large↓small subunit; [@bib39]; [@bib18]). Additionally, processed fragments of endogenous caspase-4/11 could be detected when cells were stimulated with LPS or infected with bacteria ([@bib18]; [@bib10], [@bib11]; [@bib16]; [@bib25]). However, the biological significance of caspase-11 cleavage and its role under physiological conditions remain unknown.

Results and discussion {#s02}
======================

Induction of cleaved caspase-11 fragment in macrophages in response to cytoplasmic LPS {#s03}
--------------------------------------------------------------------------------------

We and others have previously reported the appearance of a large caspase-11 subunit p26 fragment released into cell culture supernatant of bone marrow--derived macrophages (BMDMs) following noncanonical inflammasome stimulation ([Fig. 1 A](#fig1){ref-type="fig"}; [@bib18]; [@bib10]; [@bib25]). In contrast, other groups have observed caspase-11 activation and pyroptosis without detectable levels of cleaved caspase-11 ([@bib15]; [@bib41]). To optimize conditions to better detect cleaved caspase-11, we initially examined the induction of caspase-11 processing in a time course study. BMDMs were electroporated with LPS to rapidly engage noncanonical inflammasome activation and incubated with low volumes of media to increase sensitivity of detection. Cells were lysed and combined with supernatant, then run directly on SDS-PAGE without the need for any secondary protein concentration steps or immunoprecipitation. Combined cell extracts and supernatant were examined to focus exclusively on caspase-11 processing rather than cell death or the subsequent release of fragments into the supernatant. Using our optimized method, we could readily visualize the induction of caspase-11 processing, which was supported by the appearance of the large subunit p26 fragment ([Fig. 1 B](#fig1){ref-type="fig"}). The processed caspase-11 p26 fragment appeared 60 min after LPS stimulation in WT macrophages. Accordingly, the appearance of caspase-11 p26 was concomitant with a reduction in pro--caspase-11 levels. Following activation, caspase-11 enzymatically cleaves GSDMD at Asp~276~ to release the GSDMD-NT pore-forming fragment ([@bib20]; [@bib32]). In agreement with this model, induction of caspase-11 p26 processing was concurrent with the appearance of GSDMD-NT (p30) and pyroptotic death, as shown by immunoblots of extract + supernatant and lactate dehydrogenase (LDH) release into cell culture supernatant, respectively ([Fig. 1, B and C](#fig1){ref-type="fig"}). These results confirm that caspase-11 is processed into a caspase-11 p26 fragment in BMDMs undergoing pyroptosis. Besides caspase-11 p26, another band appeared around 38 kD upon LPS stimulation ([Fig. 1 B](#fig1){ref-type="fig"}). The appearance of this ∼38-kD caspase-11 band may represent a previously reported transcriptionally induced pro--caspase-11 isoform (M~61~--N~373~; [@bib39]; [@bib18]) or a partially processed fragment of caspase-11 (e.g. M~1~--D~285~ CARD large subunit or A~60~--N~373~ large-small subunit; [Fig. 1 A](#fig1){ref-type="fig"}).

![**Induction of cleaved caspase-11 fragment in macrophages in response to cytoplasmic LPS. (A)** Schematic of caspase-11 representing the CARD domain and large and small catalytic subunits. Predicted cleavage sites D59, D80, and D285 are indicated. Asterisk (\*) marks critical cysteine residue in caspase-11 catalytic site (C254). M61 is a predicted alternative start site. **(B and C)** BMDMs were treated with 1 µg/ml Pam3CSK4 for 5 h before stimulation. **(B)** Immunoblot of caspase-11, GSDMD, and actin in combined cell extract (ext) and supernatant (sup) from WT BMDMs 30, 60, and 120 min after LPS electroporation or control. **(C)** LDH release time course in WT BMDMs 30, 60, and 120 min after LPS stimulation from cells in B. Data are presented as mean ± SD (*n* = 3) in C and representative of at least two independent experiments (B and C).](JEM_20180589_Fig1){#fig1}

Caspase-11 auto-processing at Asp~285~ is essential for GSDMD processing, pyroptosis, and IL-1β release {#s04}
-------------------------------------------------------------------------------------------------------

To better understand the roles of enzymatic activity and processing of caspase-11, we established mutant knock-in (KI) mouse lines in C57BL/6N using CRISPR/Cas9 technology. To assess the contribution of caspase-11 enzymatic activity, we mutated the critical cysteine at position 254 to an alanine to generate an enzymatically inactive caspase-11 KI mouse (*Casp11^Enz\ C254A/C254A^*). Additionally, to highlight the role of caspase-11 processing, we generated a mouse harboring an aspartic acid to alanine mutation at position 285 (*Casp11^Prc\ D285A/D285A^*) to disrupt the processing site in the linker region between the large and small subunits of caspase-11 ([@bib39]; large↓small subunit, [Fig. 1 A](#fig1){ref-type="fig"}). Both newly founded mutant mouse lines, *Casp11^Enz\ C254A/C254A^* and *Casp11^Prc\ D285A/D285A^*, exhibited normal development, viability, and fertility, suggesting that blocking caspase-4/11 activation in vivo is not deleterious.

WT and *Casp11^Prc\ D285A/D285A^* BMDMs were confirmed to express comparable protein levels of caspase-11, while *Casp11^Enz\ C254A/C254A^* BMDMs expressed slightly higher levels of pro--caspase-11 (Fig. S1 A). Upon overexpression in HEK293 cells, caspase-11 can itself become a substrate and auto-cleave at VFVD~59~↓A (or FSVD~80~↓P) and MEAD~285~↓A to generate a large p26 subunit and small subunit ([Fig. 1 A](#fig1){ref-type="fig"}; [@bib39]). Consistent with this overexpression study, *Casp11^Enz\ C254A/C254A^* BMDMs failed to generate a caspase-11 p26 fragment ([Fig. 2 A](#fig2){ref-type="fig"}). Likewise, induction of caspase-11 p26 was absent in *Casp11^Prc\ D285A/D285A^* BMDMs. These data corroborate the existence of a detectable caspase-11 self-cleaved fragment generated by proteolytic processing at a nonredundant residue (Asp~285~) within the inter-subunit linker. Furthermore, conserved P~1~ and P~1~' residues in human caspase-4 (LEED~289~↓A) and other species suggest there is an evolutionarily conserved mechanism for caspase-4/11 auto-proteolysis (Fig. S1 B).

![**Caspase-11 auto-processing at Asp~285~ is essential for GSDMD processing, pyroptosis, and IL-1β release. (A--D)** BMDMs were treated with 1 µg/ml Pam3CSK4 for 5 h. **(A)** Immunoblot of caspase-11, GSDMD, and actin in extract (ext) + supernatant (sup) from WT, *Casp11^Enz\ C254A/C254A^*, and *Casp11^Prc\ D285A/D285A^* BMDMs at 60 min after LPS electroporation or control. **(B)** Cell death measured by percent YOYO-1^+^ cells from live cell images taken every 30 min over a 16-h time course following LPS electroporation of BMDMs from two mice per genotype. **(C)** LDH, IL-1β, and IL-18 release from BMDMs stimulated with transfected LPS (5 µg/ml plus FuGENE HD), ATP (5 mM), or nigericin (10 µg/ml) after 16 h, 3 h, or 30 min, respectively. **(D)** LDH, IL-1β, and IL-18 release measured from supernatants of BMDMs infected with indicated strains of bacteria. Data are representative of at least two independent experiments (A and B). Data are presented as mean ± SD (*n* = 3) and representative of at least three independent experiments (C and D).](JEM_20180589_Fig2){#fig2}

To determine the importance of caspase-11 auto-processing in pyroptosis induction, we next examined the proteolytic activation of a direct substrate of caspase-11, GSDMD. Similar to *Casp11^−/−^* BMDMs, *Casp11^Enz\ C254A/C254A^* and *Casp11^Prc\ D285A/D285A^* BMDMs failed to generate a GSDMD-NT fragment ([Fig. 2 A](#fig2){ref-type="fig"}). Since creation of GSDMD-NT is necessary for pyroptosis ([@bib20]; [@bib32]), we next assayed for the occurrence of pyroptosis by monitoring plasma membrane integrity through imaging and LDH release. The failure of *Casp11^Enz\ C254A/C254A^* and *Casp11^Prc\ D285A/D285A^* BMDMs to respond to LPS was confirmed by live-cell imaging using a cell-impermeable fluorescent dye (YOYO-1) that marks dying cells with damaged plasma cell membranes ([Fig. 2 B](#fig2){ref-type="fig"}). Accordingly, *Casp11^−/−^*, *Casp11^Enz\ C254A/C254A^*, and *Casp11^Prc\ D285A/D285A^* BMDMs were similarly unresponsive to cytoplasmic LPS as measured by LDH release, while retaining normal responses to NLRP3 (ATP and nigericin)-- or NLRC4 (flagellin)--dependent canonical inflammasome activation ([@bib22]; [@bib33]) ([Fig. 2 C](#fig2){ref-type="fig"} and Fig. S1 C). These data clearly show that caspase-11 processing at Asp~285~ is functionally required for LPS-mediated GSDMD cleavage and pyroptosis.

Beyond pyroptosis, the pore-forming GSDMD-NT can also lead to noncanonical activation of the NLRP3 inflammasome, resulting in caspase-1--dependent activation and release of the proinflammatory cytokines, IL-1β and IL-18 ([@bib18], [@bib20]). Mutating caspase-11 at either the active catalytic site (Cys~254~) or auto-cleavage site (Asp~285~) significantly reduced levels of proinflammatory cytokines released from cytoplasmic LPS-stimulated BMDMs ([Fig. 2 C](#fig2){ref-type="fig"}). These results are consistent with the attenuated GSDMD-NT formation seen in *Casp11^Enz\ C254A/C254A^* and *Casp11^Prc\ D285A/D285A^* BMDMs ([Fig. 2 A](#fig2){ref-type="fig"}). Furthermore, this defect is specific to LPS-dependent responses, as IL-1β and IL-18 levels released upon NLRP3 canonical stimuli remained unchanged ([Fig. 2 C](#fig2){ref-type="fig"} and Fig. S1 C).

To examine responses in the context of bacterial infections, we exposed BMDMs to Gram-negative bacteria (*Escherichia coli*, *Shigella flexneri*, and *Citrobacter rodentium*), which activate the caspase-11--dependent inflammasome ([@bib18]; [@bib27]). We found that both *Casp11^Enz\ C254A/C254A^* and *Casp11^Prc\ D285A/D285A^* BMDMs phenocopied *Casp11^−/−^* BMDMs by failing to secrete proinflammatory cytokines or undergo pyroptosis upon Gram-negative bacteria infection. However, they continue to respond to the canonical inflammasome (NLRC4) triggered by *Pseudomonas aeruginosa* infection ([Fig. 2 D](#fig2){ref-type="fig"}; [@bib33]).

We also confirmed that mutating caspase-11 at the processing site (Asp~285~) is unlikely to cause improper folding or result in dysfunction beyond disruption of auto-cleavage. Homology modeling of caspase-11 using the caspase-1 x-ray crystal structure ([@bib13]) shows Asp~285~ is located in a thermally flexible linker region of caspase-11 (Fig. S1 D). Additionally, WT and D285A mutant caspase-11 bound LPS equivalently in a biotin-LPS pull-down study, confirming D285A replacement does not impair the caspase-11 CARD-LPS interaction (Fig. S1 E; [@bib31]). Furthermore, when caspase-11 auto-processing was mimicked by coexpressing large and small catalytic subunits as separate constructs in HEK293T cells, both WT and D285A mutant versions showed comparable proteolytic activity as measured by GSDMD processing (Fig. S1 F).

Collectively, we provide strong genetic evidence highlighting the requirement of caspase-11 auto-processing at the inter-subunit linker for its optimal activation. Auto-proteolysis at the inter-subunit linker (large↓small subunit) mediates downstream GSDMD cleavage, rapid execution of pyroptosis, and proinflammatory cytokine release. The physiological role of cleavage at Asp~59~ or Asp~80~ (CARD↓large subunit), however, remains unclear. In the case of caspase-1, CARD↓large subunit auto-cleavage can create a p20/p10 complex that is catalytically active ([@bib35]), yet has also been reported to be relatively unstable ([@bib38]; [@bib6]).

GSDMD Asp~276~ residue is the critical nonredundant cleavage site following caspase-1/11 activation {#s05}
---------------------------------------------------------------------------------------------------

In a cell-free system using recombinant proteins, pro-GSDMD can be directly cleaved by caspase-1/11 at LLSD~276~↓G (FLTD~275~↓G in human; [@bib2]; [@bib20]; [@bib32]), an essential step in the creation of pore-forming GSDMD-NT. To genetically validate this model, we generated a mutant KI mouse (*Gsdmd^D276A/D276A^*) with an alanine replacing the aspartic acid at position 276. Our previous study used immortalized macrophages reconstituted with overexpressed GSDMD to demonstrate that the Asp~276~ to Ala mutation can abrogate processing in response to cytoplasmic LPS ([@bib20]). Consistently, GSDMD-NT was undetectable in *Gsdmd^D276A/D276A^* BMDMs after stimulation with cytoplasmic LPS ([Fig. 3 A](#fig3){ref-type="fig"}), confirming that LLSD~276~↓G is a nonredundant cleavage site for caspase-11. When *Gsdmd^D276A/D276A^* BMDMs were stimulated with ATP to activate the caspase-1 canonical inflammasome, we did not observe the 30-kD GSDMD-NT, but rather an aberrant 43-kD GSDMD fragment ([Fig. 3 A](#fig3){ref-type="fig"} and Fig. S2). This band seems to represent a previously reported nonfunctional GSDMD C-terminus p43 fragment that is aberrantly generated by caspase-3 cleavage at aspartic acid position 87 (Asp~87~; Fig. S2; [@bib34]). Accordingly, caspase-3 activation can be induced by caspase-1 in macrophages upon canonical inflammasome stimuli, although its physiological relevance remains unclear ([@bib36]; [@bib29]). It is unlikely that caspase-1 directly cleaves GSDMD at Asp~87~ since aberrant GSDMD C-terminus p43 does not appear when GSDMD is incubated with recombinant caspase-1 ([@bib2]; [@bib26]).

![**GSDMD Asp~276~ residue is the critical nonredundant cleavage site following caspase-1/11 activation. (A--D)** BMDMs were treated with 1 µg/ml Pam3CSK4 for 5 h before stimulation. **(A)** Immunoblot of GSDMD and actin in combined cell extract (ext) + supernatant (sup) from WT and *Gsdmd^D276A/D276A^* BMDMs after 60 min following control treatment, LPS electroporation, or ATP stimulation for detection of GSDMD full-length (pro), GSDMD NT (p30), and p43. **(B)** Cell death measured by percent YOYO-1^+^ cells from live cell images taken every 30 min over a 16 h time course following LPS electroporation of BMDMs from two mice per genotype. **(C)** LDH, IL-1β, and IL-18 release measured from supernatants of BMDMs stimulated with transfected LPS (5 µg/ml plus FuGENE HD), ATP (5 mM), or nigericin (10 µg/ml) after 16 h, 3 h, or 30 min, respectively. **(D)** LDH, IL-1β, and IL-18 release measured from supernatants of BMDMs infected with indicated strains of bacteria. Data are representative of at least two independent experiments (A and B). Data are presented as mean ± SD (*n* = 3) and representative of at least three independent experiments (C and D).](JEM_20180589_Fig3){#fig3}

Functionally, BMDMs from *Gsdmd^D276A/D276A^* mice were defective in pyroptosis and proinflammatory cytokine release following cytoplasmic LPS stimulation, similar to *Gsdmd^−/−^* ([Fig. 3, B and C](#fig3){ref-type="fig"}). Caspase-1 relies exclusively on GSDMD to execute pyroptosis at early time points ([@bib20]; [@bib32]). When BMDMs were stimulated with canonical inflammasome stimuli (ATP or nigericin) to activate caspase-1, *Gsdmd^D276A/D276A^* BMDMs again phenocopied *Gsdmd^−/−^* by exhibiting attenuated release of LDH, IL-1β, and IL-18 (3-h ATP and 30-min nigericin time points; [Fig. 3 C](#fig3){ref-type="fig"}). These results are consistent with the aberrant GSDMD C-terminus p43 representing a nonfunctional fragment ([@bib34]). We next determined whether processing at Asp~276~ was important under conditions with bacterial infection. *Gsdmd^D276A/D276A^* BMDMs were unresponsive to Gram-negative *C. rodentium* (noncanonical inflammasome) or *P. aeruginosa* (canonical inflammasome), as previously shown for *Gsdmd^−/−^* ([Fig. 3 D](#fig3){ref-type="fig"}). Together these data provide genetic evidence confirming that Asp~276~ is the physiological nonredundant cleavage site in GSDMD, and cleavage at this site is the final trigger to initiate pyroptosis.

Caspase-11 auto-processing and GSDMD cleavage are required to induce acute septic shock {#s06}
---------------------------------------------------------------------------------------

To further investigate the role of caspase-11 catalytic activity and auto-processing in vivo, we challenged mice with a high dose of LPS, which is a model of acute septic shock dependent on caspase-11 and GSDMD-mediated pyroptosis ([@bib40]; [@bib18], [@bib20]). Similar to *Casp11^−/−^* mice, both *Casp11^Enz\ C254A/C254A^* and *Casp11^Prc\ D285A/D285A^* were resistant to LPS-induced lethal septic shock ([Fig. 4 A](#fig4){ref-type="fig"} and Fig. S3 A). Intraperitoneal injection of LPS is also known to increase serum levels of IL-1β and IL-18 cytokines through the caspase-11--dependent NLRP3 inflammasome pathway ([@bib18]). In accordance with in vitro data ([Fig. 2 C](#fig2){ref-type="fig"}), serum IL-1β and IL-18 cytokine levels were similarly reduced in all caspase-11 mutant lines tested ([Fig. 4 B](#fig4){ref-type="fig"}). To determine if GSDMD processing was critical for resistance to acute septic shock, we also challenged *Gsdmd^D276A/D276A^* mice to high doses of LPS. Similar to *Gsdmd^−/−^* mice, *Gsdmd^D276A/D276A^* mice displayed marked resistance to LPS challenge, whereas WT mice succumbed within 24 h ([Fig. 4 C](#fig4){ref-type="fig"} and Fig. S3 B). Collectively, these in vivo data highlight the crucial roles of caspase-11 catalytic activity, caspase-11 auto-processing, and GSDMD cleavage in lethal septic shock.

![**Caspase-11 auto-processing and GSDMD cleavage are required to induce acute septic shock. (A and C)** Kaplan-Meier survival plots for mice (*n* = 10 per genotype) challenged with 54 mg/kg LPS. Adjusted P values are supplied in Figs. S3 (A and B). **(B)** Serum IL-1β and IL-18 levels 12 h after intraperitoneal injection with 20 mg/kg LPS. Each dot represents a single animal (*n* = 5); error bars represent mean ± SD. Data are representative of at least two independent experiments.](JEM_20180589_Fig4){#fig4}

Recent emerging reports have established a paradigm in which a single cut at GSDMD-Asp~276~ by caspase-1/4/5/11 can instantly perforate the cell membrane and result in pyroptotic cell death ([@bib20]; [@bib32]). Our studies with *Gsdmd^D276A/D276A^* mice provide the first genetic evidence that cleavage at Asp~276~, between the pore-forming GSDMD-NT and the self-inhibitory C-terminus, is a critical and nonredundant step in the execution of an inducible pyroptotic program. Furthermore, our studies with *Casp11^Enz\ C254A/C254A^* and *Casp11^Prc\ D285A/D285A^* mice genetically validate the hypothesis that an additional proteolytic step (caspase-11 auto-processing) precedes GSDMD cleavage. This self-proteolysis step is essential for all downstream events, including GSDMD activation, IL-1β and IL-18 release, and lethal sepsis induction, thus refining the model for noncanonical inflammasome activation.

Auto-proteolysis for optimal caspase activation is not without precedent. Caspase-8 auto-processing has been shown to be an important event for apoptosis in studies using gene targeted KI mice or bacterial artificial chromosome transgenic mice that harbor a caspase-8 auto-processing dead mutant ([@bib17]; [@bib24]). Caspase-1, another initiator caspase, is also auto-processed in response to canonical inflammasome stimuli. *Casp1^−/−^* macrophages reconstituted with caspase-1--processing dead mutants reportedly attenuate IL-1β release, but retain the ability to undergo caspase-1--dependent pyroptosis ([@bib7]; [@bib14]). However, it should be noted that the ability of caspase-1--processing dead mutant cells to induce cell death does not necessarily correlate with intact GSDMD cleavage. Caspase-1 is known to engage GSDMD-independent pyroptosis in *Gsdmd^−/−^* macrophages ([@bib20]), and GSDMD-NT induction was not examined in the reconstituted cells ([@bib7]; [@bib14]). Additional studies with primary cells from caspase-1 auto-processing dead mutant KI mice are needed to better understand the role of caspase-1 auto-processing in GSDMD activation and pyroptosis induction at physiological settings.

Although the exact mechanism for the initial caspase-11 activation step remains unclear, it likely mirrors the proximity-induced dimerization model reported for initiator apoptotic caspases ([@bib28]; [@bib5]). The lipid A moiety of LPS binds directly to the caspase-11 CARD domain and leads to the oligomerization and proximity-induced activation of caspase-11 ([@bib31]), an event likely due to the aggregation behavior of LPS. LPS-induced proximity initiates two sequential steps for activation: (1) pro--caspase-11 gains limited catalytic activity which (2) triggers large↓small subunit auto-processing to create a heterotetramer complex (\[large subunit p26/small subunit\]~2~ or \[CARD large subunit/small subunit\]~2~) with optimal catalytic activity. This fine-tuned activation through large↓small subunit self-cleavage is a crucial event for GSDMD conversion into its active pore-forming GSDMD-NT fragment. By requiring a caspase-11 auto-processing step before undergoing pyroptosis, macrophages have imposed an intrinsic safety mechanism to prevent excess or unwarranted induction of pyroptosis.

It has been hypothesized that caspase-11 is activated in the cytosol following Gram-negative bacterial infection ([@bib1]; [@bib9]). An as yet to be developed probe that can specifically detect cleaved caspase-4/11 will be a helpful tool in understanding the exact location where caspase-4/11 is activated. Our genetic studies definitively demonstrate that cleaved caspase-4/11 and cleaved GSDMD represent candidate markers for detection of pyroptotic cells in vivo*.*

Materials and methods {#s07}
=====================

Mice {#s08}
----

*Casp11*^−/−^ ([@bib18]) and *Gsdmd*^−/−^ (1,632-bp deletion; [@bib20]) mice on a C57BL/6N background were described previously. C57BL/6N mice were purchased from Charles River Laboratories and used as WT controls for all studies. *Casp11^Prc\ D285A/D285A^* mice were generated at Taconic Biosciences/Genentech from gene-targeted C57BL/6N Tac ES cells. *Casp11^Prc\ D285A/D285A^* mice were genotyped with PCR primers (5′-CCAGTTGTGCAGAGGTGTAGATCT-3′ and 5′-TCTCCACGTGGCTCAGCTT-3′) and probes (5′-FAM/ATGGA+AGCT/ZEN/GCCGC+TGT/3IABkFQ and 5′-HEX/ATG+GAA+GCT/ZEN/G+AT+GC+TGTC/3IABkFQ). *Casp11^Enz\ C254A/C254A^* mice and *Gsdmd^D276A/D276A^* mice were obtained by pronuclear or cytoplasmic injection, respectively, of C57BL/6N zygotes with 25 ng/µl WT Cas9 mRNA (Thermo Fisher), 13 ng/µl single-guide RNA prepared by MEGAshortscript T7 kit (Thermo Fisher), and 100 ng/µl donor template (PAGE-purified Ultramer, Integrated DNA Technologies). Tail DNA from resulting G0 mosaic offspring was analyzed by PCR followed by Sanger sequencing (*Casp11* C254A) including top-5 predicted off-target loci or droplet digital PCR and deep sequencing (*Gsdmd* D276A) for target and off-target mutations (top 15 predicted sites). G0 founders carrying the intended mutation and no off-targets were bred with WT C57BL/6N mice to generate G1 heterozygous mice. Sequences of single-guide RNA and donor oligos used are provided in Fig. S3 C. *Casp11^Enz\ C254A/C254A^* mice were genotyped with PCR primers (5′-CAGACATCAGACAGCACATTC and 5′-AGCAGCGTGGGAGTTC-3′) and probes (5′-FAM/CACCTCTCGCGGCCT/MGBNFQ-3′ and 5′-VIC/CACCTCTGCAGGCCT/MGBNFQ-3′). *Gsdmd^D276A/D276A^* mice were genotyped with PCR primers (5′-CCAGCAGGTAGAAGATAGG-3′, 5′-FAM/CCTCCAGATGGGATTGATG-3′, and 5′-FAM/CCAGCGGGCATTGAT-3′). The Genentech Institutional Animal Care and Use Committee approved all animal studies.

Antibodies and reagents {#s09}
-----------------------

Antibodies used include mouse GSDMD (17G2G9; Genentech; [@bib3]), caspase-11 (clone 17D9; Novus Biologicals), Myc (Novus Biologicals), FLAG (M2; Sigma-Aldrich), and actin (AC15; Novus Biologicals). Pam3CSK4, ultra-pure LPS (*E. coli* O111:B4), ultra-pure flagellin (*P. aeruginosa*), and nigericin were purchased from Invivogen. ATP was purchased from Sigma-Aldrich, YOYO-1 dye from Thermo Fisher Scientific, and Nuclear-ID DNA stain from Enzo Life Sciences.

Immunoblot {#s10}
----------

For immunoblotting (extract + supernatant) after stimulations, 5 × 10^6^ cells were prestimulated with 1 µg/ml Pam3CSK4 for 5 h on plates and electroporated with 0.5--5 µg/ml LPS in 100 µl R buffer using Neon (Life Technologies) 100 µl Tip with 1,720 Voltage, 10 Width, 2 Pulse settings. Electroporated cells were added to 200 µl Opti-MEM I media (Gibco) to make a total of 300 µl. For ATP stimulation, 5 × 10^6^ cells were prestimulated with 1 µg/ml Pam3CSK4 (as described above), then resuspended with 5 mM ATP in 300 µl Opti-MEM I media. Cells were then split into separate tubes (70 µl/tube) and incubated for indicated times. Samples were harvested by pelleting cells and transferring supernatant to a separate tube with 1× Complete Protease Inhibitor (Roche Applied Science) added to supernatant. Remaining cells were lysed in 40 µl of radioimmunoprecipitation assay (RIPA) buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1× Complete Protease Inhibitor, 1% Triton X-100, 0.1% SDS). Cell extracts were then combined with supernatant for immunoblotting. For LDH and cytokine measurement of samples for immunoblot, 8 µl of stimulated cells (∼100,000 cells) from the 300 µl Opti-MEM I cell mix (before lysing) were added to 200 µl of Opti-MEM I in a 96-well tissue culture plate to be imaged and collected. For all other immunoblots, 1.0 × 10^5^ cells were directly lysed in RIPA buffer and run as whole cell lysate.

Macrophage cell culture and stimulations {#s11}
----------------------------------------

Bone marrow cells were differentiated into macrophages in DMEM with 10% low endotoxin FBS (Omega Scientific) and 20% L929-conditioned medium for 5--6 d, then plated at ∼1.0 × 10^6^ cells/ml with 100 µl 10%FBS/DMEM in 96-well plates and cultured overnight. For stimulations, cells were prestimulated with 1 µg/ml Pam3CSK4 for 5 h where indicated and then cultured in Opti-MEM I media with indicated stimulations, 5 mM ATP, 5 µg/ml LPS plus 0.25% vol/vol FuGENE HD (Promega; [@bib19]), nigericin 10 µg/ml, or subjected to Neon electroporations. For IncuCyte imaging analysis, the Neon transfection system was used with 1,720 voltage, 10 width, 2 pulse settings and performed with 5 × 10^6^ cells plus 0.5--5 µg/ml LPS and plated at 10^5^ cells/200 µl Opti-MEM I with 200 nM YOYO-1 per 96-well. For AMAXA electroporation, 500 ng ml flagellin or 5 µg/ml LPS were electroporated into ∼5.0 × 10^5^ cells in Opti-MEM I media 24-well plates using the AMAXA 4D-Nucleofector system Y-unit (Lonza). Infections with *P. aeruginosa* (ATCC 27853; multiplicity of infection \[moi\] 25), *E. coli* (ATCC 11775, moi 30), *C. rodentium* (ATCC 51116, moi 20), or *S. flexneri* (ATCC 9199, moi 20) were for 1.5 h and then cultures were supplemented with 100 µg/ml Gentamycin (Life Technologies). Supernatants for ATP were collected after 3 h, nigericin collected after 30 min, and *P. aeruginosa* infection collected after 3 h. All other supernatants were collected after overnight incubation unless otherwise noted.

Cell death and cytokine measurements {#s12}
------------------------------------

LDH release was measured using CytoTox 96 Non-Radioactive Cytotoxicity Assay (Promega) according to manufacturer's instructions. Data calculated as percent death (signal over max death after treatment with 0.1% Triton). YOYO-1 (491/509) dye (at 200 nM final concentration) was added at the time of stimulation and scanned in green channel every 30 min to 1 h for at least 16 h on the Essen BioScience IncuCyte ZOOM at 10× magnification. Nuclear-ID was added at the last time point and scanned in red channel. IncuCyte software was used to determine total number of dead YOYO^+^ cells and Nuclear-ID^+^ (live and dead). Percent death (or percent YOYO^+^) was calculated as the number of YOYO^+^ cells divided by the total number of NuclearID^+^ cells. IL-1β was measured from cell culture supernatants and serum by mouse IL-1β tissue culture kit (Meso Scale Discovery). IL-18 was measured from cell culture supernatants and serum using mouse IL-18 ELISA (MBL International).

Homology modeling {#s13}
-----------------

Protein structure homology modeling of caspase-11 was performed using SWISS-MODEL with caspase-1 (Protein Data Bank accession no. [3E4C](3E4C){#dblnk78dc9933-9d09-9e4f-df56-41c22dd63b83}) as a template ([@bib4]).

Plasmids and transient expression {#s14}
---------------------------------

cDNAs encoding N-ter 3×Myc mouse GSDMD, WT caspase-11 catalytic large subunit (A~60~--D~285~), caspase-11 D285A mutant large subunit, caspase-11 small subunit (A~286~--N~373~), N-ter FLAG mouse caspase-1 C284A, N-ter FLAG caspase-11 C254A, and N-ter FLAG caspase-11 C254A/D285A were synthesized and subcloned into pcDNA3.1/Zeo^(+)^ (Thermo Fisher Scientific) for transient expression in HEK293T cells. For GSDMD cleavage assay, HEK293T cells (ATCC) were cultured overnight in 96-well plates at 1.2 × 10^5^ cells/ml, then transfected with total 60 ng of plasmid by using 0.16 µl Lipofectamine 2000 per well (Thermo Fisher Scientific). Cells were lysed with RIPA buffer + protease inhibitor cocktail (Roche Applied Science) 24 h after transfection. HEK293T cell lines used were regularly tested for mycoplasma.

Biotin-LPS pull-down assay {#s15}
--------------------------

The biotin-LPS pull-down study was performed as previously described ([@bib31]). In brief, HEK293T cells were transiently transfected with plasmids on 10-cm culture dishes using Lipofectamine 2000 according to manufacturer's instruction. 24 h after transfection, cells were lysed with Triton buffer (50 mM Tris-HCl, pH 7.6, 150 mM NaCl, 2 mM EDTA, 1% Triton X-100, protease inhibitor cocktail). LPS-binding proteins were precipitated with 1 µg of biotin-conjugated LPS (Invivogen) and Streptavidin Sepharose beads (GE Healthcare). Beads were washed three times with Triton buffer, and precipitates were eluted with 1× SDS sample buffer followed by SDS-PAGE and immunoblot analysis.

In vivo mouse studies {#s16}
---------------------

Female mice aged 8--10­ wk were injected intraperitoneally with 54 mg/kg LPS (*E. coli* O111: B4, Sigma-Aldrich) and monitored eight times daily for a total of 6 d. Statistical analysis was performed with log-rank (Mantel-Cox) tests using Prism, and P values were adjusted to account for multiple comparisons using Bonferroni's correction. The Genentech Institutional Animal Care and Use Committee approved all animal studies.

Online supplemental material {#s17}
----------------------------

Fig. S1 presents additional data related to [Fig. 1](#fig1){ref-type="fig"} and [Fig. 2](#fig2){ref-type="fig"} to further characterize caspase-11 mutations and corresponding KI mice. Data shows presence of capase-11 protein in all mutants and additional evidence for defective LPS responses by caspase-11 mutants. Further data are provided to show D285A is unlikely to cause unintended dysfunction beyond disruption of caspase-11 processing. Fig. S2 is related to [Fig. 3](#fig3){ref-type="fig"} and provides a schematic of the GSDMD bands seen in [Fig. 3](#fig3){ref-type="fig"}. Fig. S3 is related to [Fig. 4](#fig4){ref-type="fig"} and shows relevant P values for the data presented in [Fig. 4](#fig4){ref-type="fig"}. Also included are the gRNA and donor oligo sequences related to the generation of the KI mice using CRISPR technology.
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